The data engineer started as a casual reader of the Jeffrey Epstein files. Then he became obsessed, and built the most ...

Document database pipelines may be being affected by schema drift: a guide for developers and DBAs from 3T Software Labs' ...

Anthropic is presently focused on rolling out major advancements for Claude, pushing it toward more powerful agentic capabilities. (Image: Reuters) Anthropic’s Claude AI is once again in the midst of ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Supabase, a popular developer database platform, has been blocked in India — one of its key markets — TechCrunch has learned. New Delhi ordered internet providers to block its website, resulting in ...

Chinese RNA-based medicine developer Suzhou Ribo Life Science has filed a Hong Kong IPO, aiming to raise new funds for its lead RBD4059 drug candidate for thrombotic diseases. The small-interfering ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

American Soluna Holdings, Inc. has received a scalable loan product worth up to $100 million from sustainable infrastructure investor Generate Capital, PBC. This is stated in the company's message.

Basil writes stories across the U.S. finance file including banks, asset managers, payment firms, insurers, and exchange operators. He also covers initial public offerings on U.S. exchanges and ...